medmix AG Income Statement

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	448	483.9	486.6	477.1	457.3
Revenue Growth (YoY)	-7.42%	-0.56%	1.99%	4.33%	30.17%
Cost of Revenue	286.1	324.2	328.9	304.3	276.1
Gross Profit	161.9	159.7	157.7	172.8	181.2
Selling, General & Admin	114.9	116.4	119	103	95.6
Research & Development	19.6	25.4	25.7	23.6	23
Other Operating Expenses	-1.6	-1.3	-4.3	5.4	-0.2
Operating Expenses	132.9	140.5	140.4	132	118.4
Operating Income	29	19.2	17.3	40.8	62.8
Interest Expense	-10.7	-12.1	-10	-6.5	-8.1
Interest & Investment Income	1.3	1.1	1.3	0.7	-
Earnings From Equity Investments	-	-5.7	-	-	-
Currency Exchange Gain (Loss)	-3.2	-1.4	-2.5	-4.5	-3.3
Other Non Operating Income (Expenses)	-2.3	-0.9	-1.3	0.2	-0.3
EBT Excluding Unusual Items	14.1	0.2	4.8	30.7	51.1
Merger & Restructuring Charges	-3.2	-2.2	-0.9	-1.6	-0.3
Gain (Loss) on Sale of Investments	-	-	-	-	1.3
Gain (Loss) on Sale of Assets	0.2	0.8	2	-15.4	0.1
Asset Writedown	-3.1	-5.2	-3	-1.5	-0.9
Legal Settlements	0.9	-	-	-	-
Pretax Income	8.9	-6.4	2.9	12.2	51.3
Income Tax Expense	1.9	-	2.2	0.6	7.3
Earnings From Continuing Operations	7	-6.4	0.7	11.6	44
Minority Interest in Earnings	-0.6	-1	-0.4	-	-
Net Income	6.4	-7.4	0.3	11.6	44
Net Income to Common	6.4	-7.4	0.3	11.6	44
Net Income Growth	-	-	-97.41%	-73.64%	358.33%
Shares Outstanding (Basic)	41	41	41	41	41
Shares Outstanding (Diluted)	42	41	41	41	41
Shares Change (YoY)	0.24%	0.50%	0.25%	-0.15%	20.14%
EPS (Basic)	0.16	-0.18	0.01	0.28	1.07
EPS (Diluted)	0.15	-0.18	0.01	0.28	1.07
EPS Growth	-	-	-97.38%	-73.81%	281.77%
Free Cash Flow	33.3	48.1	9.7	11.2	57.5
Free Cash Flow Per Share	0.80	1.16	0.23	0.27	1.40
Dividend Per Share	0.100	0.500	0.500	0.500	0.500
Dividend Growth	-80.00%	-	-	-	-
Gross Margin	36.14%	33.00%	32.41%	36.22%	39.62%
Operating Margin	6.47%	3.97%	3.55%	8.55%	13.73%
Profit Margin	1.43%	-1.53%	0.06%	2.43%	9.62%
Free Cash Flow Margin	7.43%	9.94%	1.99%	2.35%	12.57%
EBITDA	72.9	68	60.8	80.2	105
EBITDA Margin	16.27%	14.05%	12.50%	16.81%	22.96%
D&A For EBITDA	43.9	48.8	43.5	39.4	42.2
EBIT	29	19.2	17.3	40.8	62.8
EBIT Margin	6.47%	3.97%	3.55%	8.55%	13.73%
Effective Tax Rate	21.35%	-	75.86%	4.92%	14.23%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.